Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Alivus Life Sciences Financial Results

Alivus Life Sciences approved FY2025-26 audited results and recommended a ₹5 per share final dividend. The company reported annual revenue from operations of ₹2,551.83 Crore.

Source

NSE filing, NSE: ALIVUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alivus Life Sciences Ltd: key numbers

Share price
₹1,399.40
Market cap
₹17,181 Cr
Revenue (annual)
₹2,552 Cr
Net profit (annual)
₹564.5 Cr
P/E (TTM)
28.5×Sector 46.1×
Promoter holding
74.85%-0.02% QoQ
FII holding
5.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alivus Life Sciences Ltd

All →

Other financial results announcements

All →